NCT04910958

Completed

Impact of COVID-19 Pandemic on Early Spontaneous Abortions a...

Hillel Yaffe Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

0199-20-HYMC

Study Type

observational

Actual enrollment (reported)

411

Locations

1 country

Sites

1

Timeline

Study Start

January 6, 2021

Actual (reported)

Primary Completion

August 9, 2022

Actual (reported)

Study Completion

August 9, 2022

Actual (reported)

Brief Summary

To see the impact the COVID-19 pandemic has had on early spontaneous abortions and early termination of pregnancy in the first trimester

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 411 participants
Study completion date: August 9, 2022
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 6, 2021
Actual (reported)
First Submitted
June 1, 2021
Actual (reported)
First Posted
June 2, 2021
Actual (reported)
Primary Completion
August 9, 2022
Actual (reported)
Study Completion
August 9, 2022
Actual (reported)

Last Updated: December 6, 2022
Status Verified: December 2022
Last Update Submitted: December 5, 2022

Conditions

Covid19 Pregnancy Loss Termination of Pregnancy

Outcome Measures

Primary Outcomes (2)

Number of early missed abortions
Number of early missed abortions in the first trimester in COVID19 time compared to years prior
Two years
Number of termination of pregnancies
Number of termination of pregnancies in the first trimester in COVID19 time compared to years prior
Two years

Secondary Outcomes (3)

Time between discovery and attendance
1 year
Comparison of reasons for termination
1 year
Comparison of Age/Religion/Demographic variables
1 year

Eligibility Criteria

Age16 Years - 45 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsFemales only

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64)

Sampling MethodNon-Probability Sample

Study Population

All women attending for early missed abortion or termination of pregnancy receiving treatment between March 11th - November 30th during the years 2017-2020 Gestational age until 12 weeks 6 days (1st trimester only)

You may qualify if:

Sponsors & Collaborators

Hillel Yaffe Medical Center
Governmentlead

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, Israel

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

Omer Mor, MD
omer.moore@gmail.com
PRINCIPAL INVESTIGATOR

Enrollment

411 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER GOV
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 1, 2021

First Posted

June 2, 2021

Study Start

January 6, 2021

Actual (reported)

NCT04842708

Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis

Not ApplicableCompleted

NCT05323760

Functional Capacity in Patients Post Mild COVID-19

Not ApplicableUnknown

NCT04590053

Allocetra-OTS in COVID-19, Phase II

Phase 2Unknown

NCT04348422

Evaluating the Immune Response for COVID-19

Completed

NCT05226767

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

Phase 2Completed

NCT04513470

Allocetra-OTS in COVID-19

Phase 1Unknown

All women attending for early missed abortion or termination of pregnancy receiving treatment between March 11th - November 30th during the years 2017-2020 Gestational age until 12 weeks 6 days (1st trimester only)

You may not qualify if:

Incomplete and complete abortions
Gestational age \>13 weeks

Contact the study team to confirm eligibility.

Primary Completion

August 9, 2022

Actual (reported)

Study Completion

August 9, 2022

Actual (reported)

Last Updated

December 6, 2022

Record last verified: 2022-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04910958
Data provider: ClinicalTrials.gov
Source updated: 2022-12-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:39:30 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (3)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations